The abstract is read at the publisher; the summary is JClub's.
GLP-1 receptor agonist uptake in people with obesity is projected to avoid up to 6.6 million deaths by 2050 and free 32 Mha of natural land under calorie reduction alone.
- Why it matters: Health benefits are known, but the effects on global food demand and land use are not quantified, limiting assessment of broader global health and environmental tradeoffs.
- What they did: Using a global food system model, the study projected outcomes to 2050 for GLP-1 uptake under two scenarios: reduced calories with unchanged diet composition, and reduced calories plus shifts toward the EAT-Lancet diet.
- The result: Adding EAT-Lancet shifts increases impacts to 7.7 million avoided deaths and 46 Mha more natural land, while lower food prices raise consumption in untreated groups, partially offsetting gains.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.